L’opération vise à renforcer la situation financière de la société et à maintenir sa stratégie de croissance SAO PAULO, 24 mai 2024 /PRNewswire/ — Oncoclínicas (B3: ONCO3), une société d’oncologie de premier plan basée en Amérique latine, a annoncé que l’entreprise avait approuvé une…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.